Orinko(SH:688219)2025-10-29 09:15Financial Performance - The company's operating revenue for Q3 2025 reached ¥1,699,505,440.47, representing an increase of 8.98% compared to the same period last year[3]. - The total profit for the period was ¥63,297,782.29, reflecting an 8.11% year-over-year growth[3]. - Net profit attributable to shareholders was ¥61,041,345.04, up by 6.91% year-over-year[3]. - Total operating revenue for the first three quarters of 2025 reached ¥4,720,527,717.26, an increase of 10% compared to ¥4,290,309,112.15 in the same period of 2024[21]. - Net profit for the first three quarters of 2025 was ¥166,975,926.73, compared to ¥156,976,776.31 in 2024, indicating an increase of about 6.4%[22]. - The company's operating profit for the first three quarters of 2025 was ¥173,472,246.62, slightly up from ¥165,306,254.85 in the previous year[21]. - The company reported a total comprehensive income of ¥176,280,492.48 for the first three quarters of 2025, compared to ¥161,260,356.07 in 2024, an increase of about 9.3%[22]. Cash Flow - The net cash flow from operating activities surged by 1,123.58% to ¥290,638,788.85, indicating improved cash management and collection efficiency[8]. - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $4.60 billion, an increase of 8.43% compared to $4.24 billion in the same period of 2024[24]. - Net cash flow from operating activities was $685.78 million, up 63.93% from $417.79 million year-over-year[24]. - Cash inflow from investment activities totaled approximately $1.11 billion, significantly higher than $287.22 million in the first three quarters of 2024[25]. - Net cash flow from investment activities was negative at -$373.67 million, an improvement from -$419.42 million in the previous year[25]. - Cash inflow from financing activities amounted to $1.09 billion, a decrease from $1.32 billion in the same period last year[25]. - Net cash flow from financing activities was $77.46 million, recovering from a negative $151.17 million in the previous year[25]. - The ending cash and cash equivalents balance increased to approximately $967.00 million, compared to $556.41 million at the end of the third quarter of 2024[25]. - The company received $1.09 billion from investment recoveries, a significant increase from $270 million in the previous year[25]. - The company reported a cash outflow of $1.48 billion for investment activities, up from $706.64 million in the same period last year[25]. Assets and Liabilities - Total assets increased by 1.77% to ¥7,120,331,630.78 compared to the end of the previous year[4]. - As of September 30, 2025, the total current assets amounted to RMB 4,263,910,527.15, an increase from RMB 4,196,330,496.81 as of December 31, 2024, reflecting a growth of approximately 1.6%[17]. - The total liabilities increased to RMB 4,263,910,527.15 from RMB 4,196,330,496.81, showing a rise of about 1.6%[18]. - The total assets as of September 30, 2025, were RMB 7,120,331,630.78, compared to RMB 6,996,698,968.36 at the end of 2024, marking an increase of approximately 1.8%[18]. - The total liabilities decreased from ¥4,836,949,984.57 in the previous year to ¥4,146,197,361.56 in 2025, a reduction of about 14.3%[21]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,992, with the largest shareholder holding 25.54% of the shares[10]. - The company has a total of 50,849,734 shares held by Hefei Langrun Asset Management Co., Ltd., representing 9.24% of the total shares as of the end of the reporting period[13]. - Shareholders' equity attributable to the parent company rose by 37.69% to ¥2,970,899,293.95, primarily due to the conversion of convertible bonds[8]. - The total equity attributable to shareholders increased to ¥2,970,899,293.95 in 2025 from ¥2,157,735,386.73 in 2024, reflecting a growth of approximately 37.7%[21]. Research and Development - Research and development expenses totaled ¥76,722,974.99, accounting for 4.51% of operating revenue, an increase of 0.04 percentage points from the previous year[4]. - Research and development expenses increased to ¥213,714,109.88 in 2025 from ¥187,818,137.22 in 2024, marking a rise of approximately 13.8%[21]. Earnings Per Share - The basic earnings per share remained stable at ¥0.12, while diluted earnings per share also held steady at ¥0.12[3]. - Basic earnings per share remained stable at ¥0.34 in 2025, compared to ¥0.34 in 2024[22]. Non-Recurring Gains - The company reported non-recurring gains of ¥3,586,680.06 for the current period, with a total of ¥19,756,710.07 for the year-to-date[6]. Accounting Standards - The company did not apply new accounting standards for the year 2025[26].